223 related articles for article (PubMed ID: 36866604)
1. Efficient Designs for Valuation Studies That Use Time Tradeoff (TTO) Tasks to Map Latent Utilities from Discrete Choice Experiments to the Interval Scale: Selection of Health States for TTO Tasks.
Che M; Pullenayegum E
Med Decis Making; 2023 Apr; 43(3):387-396. PubMed ID: 36866604
[TBL] [Abstract][Full Text] [Related]
2. Using Both Time Tradeoff and Discrete Choice Experiments in Valuing the EQ-5D: Impact of Model Misspecification on Value Sets.
Waudby-Smith I; Pickard AS; Xie F; Pullenayegum EM
Med Decis Making; 2020 May; 40(4):483-497. PubMed ID: 32517541
[No Abstract] [Full Text] [Related]
3. Latent Class Models Reveal Poor Agreement between Discrete-Choice and Time Tradeoff Preferences.
Pullenayegum EM; Pickard AS; Xie F
Med Decis Making; 2019 May; 39(4):421-436. PubMed ID: 30982403
[No Abstract] [Full Text] [Related]
4. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
[TBL] [Abstract][Full Text] [Related]
5. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
6. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
[TBL] [Abstract][Full Text] [Related]
7. Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation.
Xie S; Wu J; Xie F
Value Health; 2023 Sep; 26(9):1405-1412. PubMed ID: 37285916
[TBL] [Abstract][Full Text] [Related]
8. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
[TBL] [Abstract][Full Text] [Related]
10. Scoring the 5-level EQ-5D: can latent utilities derived from a discrete choice model be transformed to health utilities derived from time tradeoff tasks?
Pullenayegum E; Xie F
Med Decis Making; 2013 May; 33(4):567-78. PubMed ID: 23475942
[TBL] [Abstract][Full Text] [Related]
11. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.
Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O;
Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952
[TBL] [Abstract][Full Text] [Related]
12. Transforming Latent Utilities to Health Utilities: East Does Not Meet West.
Xie F; Pullenayegum E; Pickard AS; Ramos Goñi JM; Jo MW; Igarashi A
Health Econ; 2017 Dec; 26(12):1524-1533. PubMed ID: 27747973
[TBL] [Abstract][Full Text] [Related]
13. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
[TBL] [Abstract][Full Text] [Related]
14. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
[TBL] [Abstract][Full Text] [Related]
15. Toward a Smaller Design for EQ-5D-5L Valuation Studies.
Yang Z; Luo N; Oppe M; Bonsel G; Busschbach J; Stolk E
Value Health; 2019 Nov; 22(11):1295-1302. PubMed ID: 31708067
[TBL] [Abstract][Full Text] [Related]
16. Valuing EQ-5D-Y: the current state of play.
Devlin N; Pan T; Kreimeier S; Verstraete J; Stolk E; Rand K; Herdman M
Health Qual Life Outcomes; 2022 Jul; 20(1):105. PubMed ID: 35794607
[TBL] [Abstract][Full Text] [Related]
17. Exploring Differences between TTO and DCE in the Valuation of Health States.
Robinson A; Spencer AE; Pinto-Prades JL; Covey JA
Med Decis Making; 2017 Apr; 37(3):273-284. PubMed ID: 27646566
[TBL] [Abstract][Full Text] [Related]
18. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
[TBL] [Abstract][Full Text] [Related]
19. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O
Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358
[TBL] [Abstract][Full Text] [Related]
20. An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values.
Shah KK; Ramos-Goñi JM; Kreimeier S; Devlin NJ
Eur J Health Econ; 2020 Sep; 21(7):1091-1103. PubMed ID: 32506281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
